NEW YORK, July 28, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of American Renal Associates Holdings, Inc. ("ARA" or the "Company") (NYSE: ARA), concerning whether the board has breached its fiduciary duties to shareholders.
In July, UnitedHealth Group, Inc. ("UnitedHealth") sued ARA in the U.S. District Court for the Southern District of Florida, C.A. No. 9:16-cv-81180-KAM. In the complaint, UnitedHealth alleges that ARA engaged in a fraudulent scheme to obtain larger payments from UnitedHealth than were really due.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own ARA and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.